SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 52 filers reported holding SUNESIS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $684,000 | -73.4% | 2,594,925 | -58.1% | 0.04% | -82.5% |
| Q1 2020 | $2,570,000 | +22.8% | 6,194,925 | 0.0% | 0.24% | +50.9% |
| Q4 2019 | $2,092,000 | -53.1% | 6,194,925 | 0.0% | 0.16% | -66.1% |
| Q3 2019 | $4,460,000 | -9.4% | 6,194,925 | -8.5% | 0.47% | -12.7% |
| Q2 2019 | $4,921,000 | +77.0% | 6,770,425 | +195.9% | 0.54% | +72.7% |
| Q1 2019 | $2,780,000 | +192.3% | 2,287,860 | 0.0% | 0.31% | +150.8% |
| Q4 2018 | $951,000 | -71.8% | 2,287,860 | +35.8% | 0.12% | -58.1% |
| Q3 2018 | $3,369,000 | -5.7% | 1,684,636 | 0.0% | 0.30% | -15.2% |
| Q2 2018 | $3,571,000 | -22.1% | 1,684,636 | 0.0% | 0.35% | -24.8% |
| Q1 2018 | $4,582,000 | -39.2% | 1,684,636 | -17.5% | 0.46% | -49.0% |
| Q4 2017 | $7,539,000 | +90.2% | 2,043,196 | 0.0% | 0.91% | +80.4% |
| Q3 2017 | $3,964,000 | -17.1% | 2,043,196 | +15.4% | 0.50% | -32.1% |
| Q2 2017 | $4,781,000 | -24.3% | 1,770,692 | +15.0% | 0.74% | -30.9% |
| Q1 2017 | $6,315,000 | +25.2% | 1,540,323 | +10.6% | 1.07% | +6.0% |
| Q4 2016 | $5,042,000 | +58.0% | 1,392,720 | +90.7% | 1.01% | +68.6% |
| Q3 2016 | $3,192,000 | – | 730,361 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|